ClinVar Miner

Submissions for variant NM_000030.3(AGXT):c.996G>A (p.Trp332Ter)

dbSNP: rs796052064
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000186348 SCV000487124 likely pathogenic Primary hyperoxaluria, type I 2016-10-10 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001857591 SCV002223988 pathogenic not provided 2021-02-16 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with primary hyperoxaluria (PMID: 25629080). ClinVar contains an entry for this variant (Variation ID: 204141). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Trp332*) in the AGXT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AGXT are known to be pathogenic (PMID: 19479957).
Clinical Biochemistry Laboratory, Health Services Laboratory RCV000186348 SCV000239694 pathogenic Primary hyperoxaluria, type I 2014-11-27 no assertion criteria provided in vivo

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.